Clinical Trial Update: Everolimus as First-Line Therapy in Treating Patients With Prostate Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial investigating everolimus as first-line therapy for prostate cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• Everolimus (everolimus)

Snippet

Sponsor: Swiss Cancer Institute | Conditions: Prostate Cancer | Phase 2 | Status: COMPLETED